Weiss Multi-Strategy Advisers’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,831
Closed -$517K 696
2021
Q4
$517K Sell
8,831
-38
-0.4% -$2.15K 0.01% 548
2021
Q3
$526K Sell
8,869
-2,131
-19% -$167K 0.01% 550
2021
Q2
$955K Sell
11,000
-1,028
-9% -$82.8K 0.02% 498
2021
Q1
$992K Sell
12,028
-2,972
-20% -$285K 0.02% 482
2020
Q4
$1.36M Sell
15,000
-5,224
-26% -$324K 0.03% 461
2020
Q3
$808K Buy
20,224
+224
+1% +$7.82K 0.02% 445
2020
Q2
$686K Buy
20,000
+10,370
+108% +$309K 0.02% 447
2020
Q1
$214K Sell
9,630
-370
-4% -$9.36K 0.01% 385
2019
Q4
$196K Sell
10,000
-10,000
-50% -$159K ﹤0.01% 572
2019
Q3
$311K Hold
20,000
0.01% 521
2019
Q2
$406K Sell
20,000
-3,500
-15% -$63.1K 0.01% 437
2019
Q1
$413K Buy
23,500
+279
+1% +$4.4K 0.01% 448
2018
Q4
$298K Sell
23,221
-6,779
-23% -$94.5K 0.02% 388
2018
Q3
$489K Buy
+30,000
New +$355K 0.02% 446

Other funds holding FATE